VIE/DXCM (VIE/DXCM)

Vienna Stock Exchange: VIE/DXCM · EUR

€70.8

-0.40 (-0.6%)· Recorded snapshot

Market cap	26.6B
Revenue (ttm)	4.3B
Net income (ttm)	875M
EPS (ttm)	€2.27
P/E (trailing)	31.2x
P/E (forward)	27.9x

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.3B
Net income (ttm): 875M
EPS (ttm): €2.27
P/E (trailing): 31.2x
P/E (forward): 27.9x
Market cap: 26.6B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E27.9

P25 14.3P50 18.7P75 25.4

Trailing P/E31.2

P25 20.4P50 26.7P75 39.7

ROE38.5

P25 4.8P50 10.6P75 20.1

ROIC44.5

P25 5.8P50 9.5P75 18.2

Benchmarks · 1M

All VIE/DXCM indicators

Market & fundamental data

Available fields

236

Groups with data

Currency

USD

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	AT
Earnings date	2026-10-29
Employees	11,100
Employees change	800
Employees growth	7.77%
Enterprise value	EUR 26.1B
Exchange	Vienna Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1999
Industry	Medical Devices
Is primary listing	No
ISIN number	US2521311074
Last earnings date	2026-10-29
Last refreshed	2026-10-29
Last stock split date	2022-06-13
Last stock split type	Forward
Market cap	EUR 26.6B
Next earnings date	2026-10-29
Price	EUR 70.80
Price currency	EUR
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-28
Symbol	vie/DXCM
Website	https://www.dexcom.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	109.76x
Average P/E ratio (3Y)	54.77x
Average P/E ratio (5Y)	92.96x
Earnings yield	3.21%
EV/Earnings	29.86x
EV/EBIT	25.69x
EV/EBITDA	20.32x
EV/FCF	21.24x
EV/Sales	5.86x
FCF / EV yield	4.71%
FCF yield	4.62%
Forward P/E	27.9x
Graham number	17.87738
Graham upside	-74.75%
Lynch fair value	EUR 28.39
Lynch upside	-59.9%
P/(FCF - SBC) ratio	24.47x
P/(OCF - SBC) ratio	19.17x
P/B ratio	11.6x
P/E ratio	31.16x
P/FCF ratio	21.64x
P/OCF ratio	17.39x
P/S ratio	6.12x
Price / tangible book value	12.19x
Price/EBITDA ratio	21.67x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	22.92%
EBITDA margin	28.24%
Effective tax rate	21.9%
FCF margin	27.62%
Gross margin	62.47%
Operating margin	22.92%
Pretax margin	25.76%
Profit margin	20.12%
Profit per employee	EUR 79,189
Profitable quarters	18
Profitable years	7
Revenue per employee	EUR 393,624
ROA	10.33%
ROA (5Y)	5.9%
ROCE	27.8%
ROE	38.49%
ROE (5Y)	23.09%
ROIC	44.49%
ROIC (5Y)	24.11%
SBC / revenue	3.27%
Tax / revenue	5.64%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	77.35%
EPS growth (Q)	43.64%
EPS growth (QoQ)	25.83%
EPS growth 3Y	43.16%
EPS growth 5Y	12.97%
EPS growth quarters	5
EPS growth years	4
FCF growth	146.15%
FCF growth (Q)	-11.68%
FCF growth (QoQ)	-58.91%
FCF growth 3Y	44.47%
FCF growth 5Y	69.47%
Gross profit growth	22.83%
Gross profit growth (Q)	20.5%
Gross profit growth 3Y	14.94%
Gross profit growth 5Y	15.65%
Net income growth	74.93%
Net income growth (Q)	38.54%
Net income growth (QoQ)	24.86%
Net income growth 3Y	40.88%
Net income growth 5Y	12.2%
Net income growth quarters	5
Net income growth years	4
OCF growth	77.05%
OCF growth (Q)	-11.16%
OCF growth (QoQ)	-48.78%
OCF growth 10Y	42.94%
OCF growth 3Y	31.36%
OCF growth 5Y	33.72%
Operating income growth	65.76%
Operating income growth (Q)	49.72%
Operating income growth 3Y	36.47%
Operating income growth 5Y	26.98%
Revenue growth	15.54%
Revenue growth (Q)	13.08%
Revenue growth (QoQ)	9.77%
Revenue growth 10Y	26.08%
Revenue growth 3Y	15.83%
Revenue growth 5Y	18.02%
Revenue growth quarters	78
Revenue growth years	19

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -300.8M
Depreciation and amortization	EUR 236.6M
EBIT	EUR 997.1M
EBITDA	EUR 1.2B
EPS	EUR 2.27
Financing cash flow	EUR -2B
Free cash flow	EUR 1.2B
Free cash flow minus SBC	EUR 1.1B
Gross profit	EUR 2.7B
Income taxes	EUR 245.3M
Investing cash flow	EUR 464.5M
Net borrowing	EUR -1.1B
Net cash flow	EUR -48.2M
Net income	EUR 875M
Operating cash flow minus SBC	EUR 1.4B
Operating income	EUR 997.1M
Revenue	EUR 4.3B
Stock-based compensation	EUR 142.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	6.56
Book value per share	EUR 6.08
Debt / EBITDA	0.97
Debt / equity	0.53
Debt / FCF	1
Goodwill	EUR 21.6M
Interest coverage	75.94
Long-term assets	EUR 2B
Long-term liabilities	EUR 1.2B
Net cash (debt)	EUR 480.2M
Net cash / market cap	1.8%
Net cash growth	56.74%
Net debt / EBITDA	-0.39
Net debt / equity	-0.21
Net debt / FCF	-0.39
Piotroski F-Score	7
Property, plant and equipment	EUR 1.5B
Shareholders' equity	EUR 2.3B
Tangible book value	EUR 2.2B
Tangible book value per share	EUR 5.79
Total assets	EUR 5.7B
Total cash	EUR 1.7B
Total debt	EUR 1.2B
Total liabilities	EUR 3.4B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.72
Current assets	EUR 3.7B
Current liabilities	EUR 2.1B
Current ratio	1.73
Inventory turnover	2.88
Net working capital	EUR -172.8M
Quick ratio	1.37
Working capital	EUR 1.5B
Working capital turnover	2.52

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.61%
Shareholder yield	2.61%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 66.27
1D price change	-0.56%
1M price change	-7.33%
1M total return	-7.33%
1W price change	-7.57%
1W total return	-7.57%
1Y price change	16.56%
1Y return CAGR	16.57%
1Y total return	16.56%
20-day SMA	EUR 74.92
200-day SMA	EUR 64.68
3M price change	9.26%
3M total return	9.26%
3Y price change	-18.31%
3Y return CAGR	-6.52%
3Y total return	-18.31%
50-day SMA	EUR 75.78
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 79.40
52-week high date	2026-08-24
52-week low	EUR 47.32
52-week low date	2025-11-10
5Y price change	-42.03%
5Y return CAGR	-10.33%
5Y total return	-42.03%
6M price change	34.09%
6M total return	34.09%
All-time high	EUR 144.70
All-time high date	2021-11-18
All-time low	EUR 47.32
All-time low date	2025-11-10
Average true range (ATR)	EUR 1.41
Average volume	0
Change from 52-week high	-10.83%
Change from 52-week low	49.62%
Change from all-time high	-51.07%
Change from all-time low	49.62%
Change from open	1.72%
Day's gap	-2.25%
High price	EUR 71.00
Low price	EUR 69.60
Monthly RSI	49.99
Open price	EUR 69.60
Position in 52-week range	85.71%
Previous close	EUR 71.20
Price vs 150-day SMA	6.83%
Price vs 20-day SMA	-5.5%
Price vs 200-day SMA	9.47%
Price vs 50-day SMA	-6.57%
Relative volume	3.93
RSI	35.58
Sharpe ratio	0.56
Sharpe ratio (3Y)	0
Sharpe ratio (5Y)	-0.06
Sortino ratio	0.95
Sortino ratio (3Y)	0.12
Sortino ratio (5Y)	0.03
Weekly RSI	51.34
YTD price change	23.58%
YTD total return	23.58%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	376M
Shares change (QoQ)	-0.89%
Shares change (YoY)	-2.61%
Shares held by insiders	0.24%
Shares held by institutions	104.38%
Short ratio	3.4 days

Deeper analysis on VIE/DXCM

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/DXCM report

Is a complete VIE/DXCM research report available?

No complete published report is available for vie/DXCM (VIE/DXCM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/DXCM (VIE/DXCM)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/DXCM

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All VIE/DXCM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/DXCM

Frequently asked questions